Invention Grant
- Patent Title: Abuse-resistant oral dosage forms and method of use thereof
- Patent Title (中): 耐药性口服剂型及其使用方法
-
Application No.: US13863764Application Date: 2013-04-16
-
Publication No.: US08703186B2Publication Date: 2014-04-22
- Inventor: Atul M. Mehta
- Applicant: Elite Laboratories, Inc.
- Applicant Address: US NJ Northvale
- Assignee: Elite Laboratories, Inc.
- Current Assignee: Elite Laboratories, Inc.
- Current Assignee Address: US NJ Northvale
- Agency: Baker & Hostetler LLP
- Main IPC: A61K31/485
- IPC: A61K31/485

Abstract:
An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but whereby a physical alteration of the oral dosage form results in a release of the therapeutically effective amount of the opioid antagonist. An embodiment of the oral dosage form includes an opioid-antagonist layer coated onto a biologically inert pellet, and a non-releasing membrane coated onto the opioid-antagonist layer. Optionally, the oral dosage form can also include an opioid agonist, such that a method of preventing the abuse of an oral dosage form of an opioid agonist is provided by forming the oral dosage form including an opioid agonist and an opioid antagonist.
Public/Granted literature
- US20130230596A1 Abuse-Resistant Oral Dosage Forms And Method Of Use Thereof Public/Granted day:2013-09-05
Information query
IPC分类: